These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9407720

  • 1. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
    Molica S, Mannella A, Crispino G, Dattilo A, Levato D.
    Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S.
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E, Carrara P, Morilla R, Matutes E.
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F, Maconi M, Albertazzi L, Gamberi B, Gugliotta L, Brini M.
    Lab Hematol; 2006 May; 12(4):187-92. PubMed ID: 17118768
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J, Babusíková O.
    Neoplasma; 2004 May; 51(2):97-102. PubMed ID: 15190418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2003 May; 50(6):408-15. PubMed ID: 14689061
    [Abstract] [Full Text] [Related]

  • 10. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P, Tiribelli M, Barbarotto E, Celeghini C, Michelutti A, Masolini P, Fanin R, Zauli G.
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [Abstract] [Full Text] [Related]

  • 11. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M, Sukova V, Coupek P, Brychtova Y, Mayer J.
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
    Santini V, Gozzini A, Scappini B, Caporale R, Zoccolante A, Rigacci L, Gelardi E, Grossi A, Alterini R, Ferrini PR.
    Haematologica; 1999 Oct; 84(10):897-904. PubMed ID: 10509037
    [Abstract] [Full Text] [Related]

  • 13. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F, Mangiola M, Rapezzi D, Zupo S, Oliva BM, Ferraris AM, Spriano M, Rossi E, Stelitano C, Callea V, Cutrona G, Ferrarini M.
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [Abstract] [Full Text] [Related]

  • 14. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
    Molica S, Vitelli G, Levato D, Levato L, Dattilo A, Gandolfo GM.
    Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
    [Abstract] [Full Text] [Related]

  • 15. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
    Goolsby C, Paniagua M, Tallman M, Gartenhaus RB.
    Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
    [Abstract] [Full Text] [Related]

  • 16. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S, Vitelli G, Levato D, Crispino G, Dell'Olio M, Dattilo A, Matera R, Gandolfo GM, Musto P.
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [Abstract] [Full Text] [Related]

  • 17. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S, Rumi C, Puggioni P, Barberi T, Di Mario A, Larocca LM, Leone G.
    Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
    [Abstract] [Full Text] [Related]

  • 18. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.
    Bannerji R, Kitada S, Flinn IW, Pearson M, Young D, Reed JC, Byrd JC.
    J Clin Oncol; 2003 Apr 15; 21(8):1466-71. PubMed ID: 12697868
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
    Pers JO, Berthou C, Porakishvili N, Burdjanadze M, Le Calvez G, Abgrall JF, Lydyard PM, Youinou P, Jamin C.
    Leukemia; 2002 Jan 15; 16(1):44-52. PubMed ID: 11840262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.